Search

Author/Creator Weiss, Sivan

1. A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects. (November 2018)

Authors:
Cohen-Barak, Orit; Weiss, Sivan; Rasamoelisolo, Michele; Faulhaber, Nicola; Yeung, Paul P; Loupe, Pippa S; Yoon, Esther; Gandhi, Mohit D; Spiegelstein, Ofer; Aycardi, Ernesto
Journal:
Cephalalgia
Issue:
Volume 38:Number 13(2018)
Page Start:
1960
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users. Issue 4 (August 2015)

Authors:
Shram, Megan J.; Cohen-Barak, Orit; Chakraborty, Bijan; Bassan, Merav; Schoedel, Kerri A.; Hallak, Hussein; Eyal, Eli; Weiss, Sivan; Gilgun, Yossi; Sellers, Edward M.; Faulknor, Janice; Spiegelstein, Ofer
Journal:
Journal of clinical psychopharmacology
Issue:
Volume 35:Issue 4(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users. Issue 4 (August 2015)

Authors:
Shram, Megan J.; Cohen-Barak, Orit; Chakraborty, Bijan; Bassan, Merav; Schoedel, Kerri A.; Hallak, Hussein; Eyal, Eli; Weiss, Sivan; Gilgun, Yossi; Sellers, Edward M.; Faulknor, Janice; Spiegelstein, Ofer
Journal:
Journal of clinical psychopharmacology
Issue:
Volume 35:Issue 4(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗